Equity Overview
Price & Market Data
Price: $3.33
Daily Change: +$0.03 / 0.90%
Daily Range: $3.30 - $3.37
Market Cap: $144,085,936
Daily Volume: 5,229
Performance Metrics
1 Week: 18.28%
1 Month: -11.76%
3 Months: -29.79%
6 Months: -33.33%
1 Year: -42.21%
YTD: -28.26%
Company Details
Employees: 153
Sector: Health technology
Industry: Medical specialties
Country: Belgium
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.